Microfluidic multitissue platform for advanced embryotoxicity testing in vitro
OPEN ACCESS
Author / Producer
Date
2019-07
Publication Type
Journal Article
ETH Bibliography
yes
Citations
Altmetric
OPEN ACCESS
Data
Rights / License
Abstract
The integration of metabolic competence in developmental toxicity assays in vitro is of fundamental importance to better predict adverse drug effects. Here, a microfluidic hanging‐drop platform is presented that seamlessly integrates liver metabolism into the embryonic stem cell test (EST). Primary human liver microtissues (hLiMTs) and embryoid bodies (EBs) are combined in the same fluidic network, so that hLiMT‐generated metabolites are directly transported to the EBs. Gravity‐driven flow through the network enables continuous intertissue communication, constant medium turnover, and, most importantly, immediate exchange of metabolites. As a proof of concept, the prodrug cyclophosphamide is investigated and a fourfold lower ID50 concentration (50% inhibition of EB differentiation) is found after biotransformation, which demonstrates the potentially adverse effects of metabolites on embryotoxicity. The metaEST platform provides a promising tool to increase the predictive power of the current EST assay by more comprehensively including and better reflecting physiological processes in in vitro tests.
Permanent link
Publication status
published
External links
Editor
Book title
Journal / series
Volume
6 (13)
Pages / Article No.
1900294
Publisher
Wiley-VCH
Event
Edition / version
Methods
Software
Geographic location
Date collected
Date created
Subject
3D microtissues; Body-on-a-chip; Developmental toxicity; Embryonic stem cell tests; Microfluidics
Organisational unit
03684 - Hierlemann, Andreas / Hierlemann, Andreas
Notes
Funding
Related publications and datasets
Is part of: https://doi.org/10.3929/ethz-b-000518182